Adaptive Biotechnologies (ADPT) Operating Margin (2018 - 2026)
Adaptive Biotechnologies' (ADPT) quarterly Operating Margin came in at 22.04% in Q2 2026, up 2048.0% year-over-year from 1.03% in Q2 2025, and up 18.67% quarter-over-quarter from 27.1% in Q1 2026.
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) Operating Margin (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has disclosed Operating Margin across 9 years of filings, most recently posting 22.04% for Q2 2026.
- In Q2 2026, Operating Margin rose 2048.0% year-over-year to 22.04%; the TTM figure through Jun 2026 stood at 12.16% (up 4686.0% YoY), while the FY2025 annual figure was 20.62%, up 7021.0% from the prior year.
- Operating Margin came in at 22.04% for Q2 2026 at Adaptive Biotechnologies, up from 27.1% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 10.95% in Q3 2025 to a low of 163.3% in Q1 2022.
- Average Operating Margin over 5 years is 83.96%, with a median of 83.14% recorded in 2022.
- Year-over-year, Operating Margin surged 9140 bps in 2022 and sank 8423 bps in 2023.
- Over 5 years, Operating Margin stood at 70.99% in 2022, then slumped by 119 bps to 155.22% in 2023, then soared by 54 bps to 71.3% in 2024, then jumped by 75 bps to 17.82% in 2025, then fell by 24 bps to 22.04% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 22.04% in Q2 2026, 27.1% in Q1 2026, and 17.82% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -10.07% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 15.08% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 12.10% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -38.55% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | -19.85% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 10.21% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 34.17% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 5.03% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -22.04% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -1.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.04% |
| Mar 31, 2026 | -27.10% |
| Dec 31, 2025 | -17.82% |
| Sep 30, 2025 | 10.95% |
| Jun 30, 2025 | -42.52% |
| Mar 31, 2025 | -56.45% |
| Dec 31, 2024 | -71.30% |
| Sep 30, 2024 | -70.27% |
| Jun 30, 2024 | -109.56% |
| Mar 31, 2024 | -116.45% |
| Dec 31, 2023 | -155.22% |
| Sep 30, 2023 | -134.38% |
| Jun 30, 2023 | -97.74% |
| Mar 31, 2023 | -151.92% |
| Dec 31, 2022 | -70.99% |
| Sep 30, 2022 | -94.98% |
| Jun 30, 2022 | -120.25% |
| Mar 31, 2022 | -163.30% |
| Dec 31, 2021 | -162.39% |
| Sep 30, 2021 | -142.71% |